Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In


kSORT is a non-invasive molecular blood test developed for the detection and surveillance of renal transplant rejection with the goal of driving preemptive clinical interventions and improved outcomes.

Anticipating Launch of kSORT – Check back for updates!

kSORT
  • is a non-invasive, accurate and precise genomic blood test
  • test results have a high correlation of rejection diagnosis at the time of biopsy
  • is built on legacy studies including over 1116 patients across 20 global transplant centers
  • has the potential to predict damage to the allograft before current diagnostic tools
  • peer reviewed assessment of 558 samples from 436 patients in the AART study
  • will provide for the conservation pf organs, maintaining function and improving health

The kSORT Assay to Detect Renal Transplant Patients at High Risk for Acute Rejection: Results of the Multicenter AART Study
Go To Research Article

A Model to Explore the Potential Budget Impact of a Novel Screening Tool for the Detection of Subclinical Rejection among Kidney Transplant Patients
Open kSORT Poster


Meet Our Scientific Advisory Board

Meet the Inventor of KSORT - Minnie Sarwal